Date published: 2025-10-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

TNFα-IP 1 Inhibitors

Chemical inhibitors of TNFα-IP1 encompass a variety of compounds that target distinct signaling pathways implicated in the regulation of this protein. Cyclosporin A, for instance, inhibits calcineurin, which in turn prevents the activation of NF-AT, a transcription factor that normally enhances the expression of genes related to inflammation, including those involving TNFα-IP1. Dexamethasone operates through inhibition of the NF-κB pathway, thereby reducing the activity of TNFα-IP1 by curtailing the transcription of genes that partake in the inflammatory response. Aspirin achieves its inhibitory effect on TNFα-IP1 by obstructing cyclooxygenase enzymes, leading to a reduction in prostaglandin synthesis, which is crucial for inflammatory signaling processes that TNFα-IP1 engages in. Parthenolide also targets the NF-κB pathway, but it does so by preventing IκB kinase activity, which results in a decrease in TNFα-IP1's role within the pro-inflammatory signaling cascade.

Adding to the repertoire, SP600125 suppresses JNK activity, which is pivotal in the signaling pathways that regulate TNFα-IP1 function, especially in response to stress and cytokines. Bay 11-7082 executes its function by irreversibly inhibiting IκBα phosphorylation, consequently inhibiting NF-κB activity and reducing TNFα-IP1's contribution to this pathway. Similarly, SB203580's selective inhibition of p38 MAPK dampens the MAPK pathway's regulation of TNFα-IP1 activity. PD98059 and U0126, inhibitors of MEK, lead to a downstream reduction in ERK activation in the MAPK pathway, which is influential in regulating TNFα-IP1 activity related to cellular stress signals. PI3K inhibitors LY294002 and Wortmannin result in decreased AKT phosphorylation, thus inhibiting the PI3K/AKT pathway where TNFα-IP1 is involved in mediating signals for cell survival and inflammation. Lastly, Rapamycin's inhibition of mTOR, a central regulator of cell growth, can lead to a concomitant decrease in TNFα-IP1 function as it plays a part in these cellular processes.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Cyclosporin A

59865-13-3sc-3503
sc-3503-CW
sc-3503A
sc-3503B
sc-3503C
sc-3503D
100 mg
100 mg
500 mg
10 g
25 g
100 g
$62.00
$90.00
$299.00
$475.00
$1015.00
$2099.00
69
(5)

Cyclosporin A inhibits calcineurin, which indirectly inhibits TNFα-IP1 by preventing the activation of NF-AT, a transcription factor that increases the expression of genes related to inflammation and TNFα-IP1 is implicated in this pathway.

Dexamethasone

50-02-2sc-29059
sc-29059B
sc-29059A
100 mg
1 g
5 g
$76.00
$82.00
$367.00
36
(1)

Dexamethasone inhibits the NF-κB pathway, which reduces the activity of TNFα-IP1 by decreasing the transcription of genes that are involved in inflammatory responses where TNFα-IP1 has a role.

Aspirin

50-78-2sc-202471
sc-202471A
5 g
50 g
$20.00
$41.00
4
(1)

Aspirin inhibits cyclooxygenase enzymes, leading to reduced prostaglandin synthesis. This reduction in prostaglandins can decrease the inflammatory signaling pathways in which TNFα-IP1 is involved.

Parthenolide

20554-84-1sc-3523
sc-3523A
50 mg
250 mg
$79.00
$300.00
32
(2)

Parthenolide inhibits the NF-κB pathway by preventing IκB kinase activity, which results in the functional inhibition of TNFα-IP1 by limiting its role in the pro-inflammatory signaling cascade.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 inhibits JNK activity, which is involved in the signaling pathways that regulate TNFα-IP1 function, particularly in response to stress and cytokines.

BAY 11-7082

19542-67-7sc-200615B
sc-200615
sc-200615A
5 mg
10 mg
50 mg
$61.00
$83.00
$349.00
155
(1)

Bay 11-7082 irreversibly inhibits IκBα phosphorylation, thereby inhibiting NF-κB activity and diminishing the functional contribution of TNFα-IP1 in the NF-κB signaling pathway.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

SB203580 selectively inhibits p38 MAPK, which is part of the MAPK pathway that regulates TNFα-IP1 activity, particularly in cells responding to stress and cytokines.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

PD98059 selectively inhibits MEK, which is upstream of the MAPK/ERK pathway, leading to decreased activation of ERK and subsequent reduction in TNFα-IP1 activity within this signaling cascade.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY294002 inhibits PI3K, which reduces AKT phosphorylation and activity, thereby inhibiting the PI3K/AKT pathway where TNFα-IP1 is involved in mediating cell survival signals.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Rapamycin inhibits mTOR, which is a key regulator of cell growth and proliferation. TNFα-IP1 is implicated in these processes, so inhibition of mTOR can lead to decreased TNFα-IP1 function.